Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -46.87%180.48M | ---- | -25.25%559.76M | ---- | -26.79%339.68M | ---- | -32.97%748.86M | ---- | -14.32%464M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | -175.01%-713.85K | ---- | 88.55%-513.79K | ---- | 173.64%951.69K | ---- | -368.06%-4.49M | ---- | -49.40%-1.29M |
| Impairment and provisions: | ---- | 855.90%171.79M | ---- | 45.73%214.44M | ---- | -72.56%17.97M | ---- | -8.99%147.15M | ---- | 38.20%65.49M |
| -Other impairments and provisions | ---- | 41.59%21.28M | ---- | 235.10%45.68M | ---- | 11.81%15.03M | ---- | 1,328.08%13.63M | ---- | 142.35%13.44M |
| Revaluation surplus: | ---- | 212.82%236.21K | ---- | -115.03%-210.24K | ---- | -112.68%-209.36K | ---- | 174.95%1.4M | ---- | 258.85%1.65M |
| Asset sale loss (gain): | ---- | 97.59%-22.27K | ---- | -71.19%-2.12M | ---- | -150.68%-925.63K | ---- | 7.00%-1.24M | ---- | -8,117.86%-369.25K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 97.59%-22.27K | ---- | -71.19%-2.12M | ---- | -150.68%-925.63K | ---- | 7.00%-1.24M | ---- | -8,117.86%-369.25K |
| Depreciation and amortization: | ---- | 27.42%196.05M | ---- | 27.22%330.6M | ---- | 33.21%153.87M | ---- | 34.35%259.86M | ---- | 21.54%115.51M |
| -Amortization of intangible assets | ---- | 40.76%62.74M | ---- | 15.62%106.76M | ---- | 23.92%44.58M | ---- | 78.74%92.34M | ---- | 41.66%35.97M |
| -Other depreciation and amortization | ---- | 0.99%8.44M | ---- | 0.91%16.79M | ---- | -0.81%8.36M | ---- | 12.62%16.64M | ---- | 19.27%8.43M |
| Financial expense | ---- | -8.52%23.6M | ---- | 72.82%39.05M | ---- | 511.51%25.79M | ---- | 280.81%22.6M | ---- | -1,377.15%-6.27M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -79.80%-70.57M | ---- | 93.07%-125.68M | ---- | 97.21%-39.25M | ---- | -166.24%-1.81B | ---- | -577.88%-1.4B |
| Accounts receivable (increase)decrease | ---- | 16.27%-343.61M | ---- | -74.69%-417.85M | ---- | 12.66%-410.37M | ---- | 67.49%-239.2M | ---- | 5.02%-469.85M |
| Accounts payable increase (decrease) | ---- | 121.20%23.85M | ---- | 40.25%92.28M | ---- | -87.46%10.78M | ---- | -55.43%65.8M | ---- | -68.76%85.97M |
| Special items of business | ---- | -84.61%4.44M | ---- | -59.61%42.71M | ---- | -51.16%28.82M | ---- | -20.30%105.73M | ---- | -19.43%59.02M |
| Adjustment items of business operations | 263.30%419.1M | 84.22%181.1M | -351.31%-26.59M | 184.75%689.76M | 110.46%115.36M | 108.55%98.31M | 102.02%10.58M | -531.51%-813.9M | -514.03%-1.1B | -549.25%-1.15B |
| Net cash from operations | 263.30%419.1M | 45.94%185.53M | -351.31%-26.59M | 203.43%732.47M | 110.46%115.36M | 111.66%127.13M | 102.02%10.58M | -320.42%-708.17M | -514.03%-1.1B | -431.33%-1.09B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 842.25%2.2M | 170.01%1.37M | -41.45%433.16K | 20.15%3.94M | -94.47%233.01K | -86.31%506.81K | -18.48%739.86K | -49.14%3.28M | 202.50%4.21M | 255.94%3.7M |
| Sale of fixed assets | -69.61%647.46K | -26.02%46.22K | 852.38%14K | 479.15%13.71M | 726.40%2.13M | -74.74%62.47K | -99.66%1.47K | -6.36%2.37M | 2,686.09%257.8K | 4,022.50%247.35K |
| Purchase of fixed assets | 18.02%-198.12M | 19.13%-158.16M | 52.96%-62.39M | 25.62%-632.95M | 50.73%-241.66M | 45.09%-195.57M | 47.67%-132.65M | -8.74%-850.93M | -7.49%-490.45M | -3.11%-356.17M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---15M | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | 37.02%1.04B | 162.60%734.2M | 87.44%300.18M | 52.48%1.2B | 23.00%761.34M | 565.87%279.59M | -27.72%160.15M | -31.34%787M | 61.71%618.96M | -77.98%41.99M |
| Cash on investment | -1.26%-1.04B | -69.02%-693M | -12.83%-299M | -95.58%-1.32B | -100.04%-1.03B | ---410M | 0.58%-265M | -31.97%-677M | -281.41%-514.9M | ---- |
| Other items in the investment business | -54.47%749.88K | -5.37%749.88K | 251.79%749.88K | -90.06%366.34K | -48.60%1.65M | -71.91%792.46K | -92.37%213.16K | -52.55%3.69M | -49.44%3.2M | -55.06%2.82M |
| Net cash from investment operations | 61.62%-194.33M | 64.64%-114.8M | 74.63%-60.01M | -3.06%-754M | -33.69%-506.31M | -5.60%-324.62M | 19.63%-236.55M | -452.09%-731.6M | -88.63%-378.72M | -108.50%-307.41M |
| Net cash before financing | 157.49%224.78M | 135.82%70.74M | 61.67%-86.6M | 98.50%-21.54M | 73.61%-390.95M | 85.87%-197.49M | 72.42%-225.97M | -862.70%-1.44B | -2,360.56%-1.48B | -869.45%-1.4B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -1.11%1.05B | -1.28%787.87M | -31.12%307M | 3.29%1.73B | -17.02%1.06B | -25.12%798.09M | 34.84%445.72M | 2,037.33%1.68B | --1.28B | --1.07B |
| Refund | -42.84%-1.18B | -10.64%-798.99M | 27.44%-327.1M | -511.30%-1.55B | -2,217.91%-823.76M | -1,932.03%-722.16M | ---450.77M | -243.79%-253.27M | 52.44%-35.54M | 52.44%-35.54M |
| Dividends paid - financing | 23.61%-93.11M | 76.95%-19.5M | 20.27%-9.89M | 3.63%-131.96M | 3.03%-121.88M | -1,242.48%-84.6M | -1,502.93%-12.41M | -148.36%-136.93M | -137.55%-125.7M | -1,047.14%-6.3M |
| Absorb investment income | ---- | ---- | ---- | 31.89%56.44M | --14.54M | --14.54M | ---- | -92.57%42.79M | ---- | ---- |
| Other items of the financing business | 21.39%-12.37M | 59.78%-5.39M | 38.53%-4.2M | -2.72%-22.19M | 8.33%-15.73M | -47.47%-13.4M | -4.14%-6.83M | -2.91%-21.61M | -12.95%-17.16M | -27.91%-9.08M |
| Net cash from financing operations | -311.94%-235.79M | -378.17%-36.01M | -40.76%-34.19M | -93.24%88.63M | -89.86%111.25M | -100.74%-7.53M | -107.51%-24.29M | 159.67%1.31B | 178.12%1.1B | 1,331.89%1.01B |
| Effect of rate | 37.21%-5.95M | 30.53%-3.88M | 14.54%-1.8M | 54.07%3.28M | -11.45%-9.47M | -275.74%-5.59M | -9.21%-2.1M | -80.93%2.13M | -23,010.57%-8.5M | 43.19%-1.49M |
| Other items affecting net cash | 0.00%-0.01 | ---- | --0.01 | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- |
| Net Cash | 96.06%-11.02M | 116.94%34.72M | 51.73%-120.79M | 151.81%67.09M | 27.27%-279.7M | 46.47%-205.02M | 49.55%-250.26M | -118.68%-129.49M | -183.63%-384.56M | -485.75%-383M |
| Begining period cash | 7.09%1.06B | 7.09%1.06B | 7.09%1.06B | -11.37%992.92M | -11.37%992.92M | -11.37%992.92M | -11.37%992.92M | 169.46%1.12B | 169.46%1.12B | 169.46%1.12B |
| Cash at the end | 48.68%1.05B | 39.86%1.09B | 27.03%940.71M | 7.09%1.06B | -3.23%703.76M | 6.32%782.32M | 19.01%740.56M | -11.37%992.92M | -16.94%727.22M | 43.59%735.8M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.